Cytokines, peptides, and signaling molecules secreted by contracting skeletal muscle (myocytes) that exert endocrine, paracrine, and autocrine effects throughout the body. Myokines transform muscle tissue into a functional endocrine organ, mediating the systemic anti-inflammatory, metabolic, neuroplastic, and immune-regulatory benefits of physical activity. Unlike cytokines released from adipose tissue or activated immune cells, muscle-derived myokines predominantly promote metabolic health and inflammatory resolution.
Think of your muscles as a pharmacy that only opens when you move. When you're sedentary, the pharmacy stays locked—shelves stocked but doors closed. During muscle contraction, the pharmacy swings open and begins dispensing prescriptions into your bloodstream: anti-inflammatory medicines, metabolic regulators, brain fertilizers, and immune modulators. The harder you work the muscles, the more intensely the pharmacy operates—light walking opens a few registers, but high-intensity interval training or resistance training throws open every counter and fills prescriptions at maximum speed. Here's the crucial part: IL-6 dispensed from this muscle-pharmacy is chemically identical to IL-6 from fat tissue or infection, but it arrives with completely different instructions. When IL-6 leaves the muscle pharmacy, it's packaged with anti-inflammatory tags and metabolic helpers—it tells fat cells to release energy, tells the liver to improve Insulin sensitivity, and signals the immune system to dial down inflammation. The same molecule from fat tissue or infection comes wrapped in pro-inflammatory packaging. Context is everything. If the pharmacy stays closed (sedentary lifestyle, low muscle mass), you lose this beneficial signaling, and the only IL-6 around comes from less helpful sources. The muscle pharmacy doesn't just dispense one product—it releases dozens of myokines simultaneously, creating a coordinated wave of systemic benefit that reaches your brain, bones, gut, and immune cells.
Myokine release is triggered by muscle contraction through multiple converging pathways that sense metabolic demand, mechanical stress, and energy depletion:
Contraction-Induced Signaling Cascade:
Muscle contraction → calcium release from sarcoplasmic reticulum → activation of calcium-dependent kinases (CaMK, calcineurin) → activation of transcription factors (NFAT, CREB, NF-κB) → myokine gene transcription → protein synthesis → vesicular secretion into circulation
Energy Sensor Pathway:
ATP depletion → AMP accumulation → AMPK activation → PGC-1α upregulation → mitochondrial biogenesis + myokine transcription (particularly IL-6, IL-15, Irisin)
Mechanical Stress Pathway:
Muscle fiber stretch/contraction → mechanosensitive ion channels (Piezoelectric channels) → calcium influx → downstream kinase activation → myokine secretion
Key Myokines and Their Specific Mechanisms:
Interleukin-6 (IL-6) from Muscle:
- Released in proportion to muscle mass engaged × contraction intensity × duration
- Increases up to 100-fold during prolonged exercise (>10 pg/mL baseline to >1000 pg/mL during marathon)
- Acts via IL-6 receptor → JAK-STAT pathway
- Downstream effects: → lipolysis via hormone-sensitive lipase activation → hepatic glucose production (acute phase) → Insulin sensitization (chronic adaptation) → IL-10 induction (anti-inflammatory cascade)
- Critically: NO concurrent TNF-α or IL-1β elevation (unlike infection-derived IL-6)
IL-10:
- Released 30-60 minutes post-IL-6 elevation
- Classic anti-inflammatory cytokine
- Suppresses TNF-α, IL-1β, and pro-inflammatory macrophage activation
- Acts via IL-10 receptor → STAT3 → SOCS3 → inhibition of NF-κB and pro-inflammatory gene transcription
IL-15:
- Constitutively expressed in muscle, released with contraction
- Promotes muscle protein synthesis (anabolic)
- Reduces adipose tissue mass (lipolytic)
- Enhances NK cell and CD8+ T cell function
Irisin:
BDNF (muscle-derived):
IL-8 (CXCL1):
- Angiogenic myokine
- Promotes capillary formation in contracting muscle
- Enhances glucose uptake and metabolic capacity
Myonectin:
- Promotes fatty acid uptake in adipocytes and liver
- Links muscle contraction to systemic lipid metabolism
graph TD
A[Muscle Contraction] --> B["Ca²⁺ Release"]
A --> C[ATP Depletion]
A --> D[Mechanical Stress]
B --> E[CaMK/Calcineurin]
C --> F[AMPK Activation]
D --> G[Mechanosensor Activation]
E --> H["Transcription Factors:<br/>NFAT, CREB, NF-κB"]
F --> I["PGC-1α Upregulation"]
G --> H
H --> J[Myokine Gene Transcription]
I --> J
J --> K[IL-6 Secretion]
J --> L[IL-15 Secretion]
J --> M[Irisin Secretion]
J --> N[BDNF Secretion]
J --> O[IL-10 Secretion]
K --> P["Lipolysis<br/>HSL Activation"]
K --> Q["Hepatic Insulin<br/>Sensitivity"]
K --> R[IL-10 Induction]
M --> S["WAT → BAT<br/>Browning"]
M --> T[Hippocampal BDNF]
N --> U["Neuroplasticity<br/>Neurogenesis"]
L --> V["Muscle Anabolism<br/>NK Cell Enhancement"]
O --> W["TNF-α/IL-1β<br/>Suppression"]
style K fill:#90EE90
style O fill:#90EE90
style M fill:#FFD700
style N fill:#87CEEB
Myokines provide the mechanistic explanation for why physical activity is therapeutic across virtually every chronic disease in cPNI—they are the molecular mediators of exercise benefit. This transforms clinical practice from vague "exercise is good" recommendations to precise, mechanism-based prescriptions.
Chronic Inflammation Conditions (Metamodel 1 - Chronic Inflammation):
Metabolic Dysfunction (Metamodel 3 - Metabolic Flexibility):
- Myokines drive glucose metabolism improvements independent of weight loss
- IL-6 from muscle increases GLUT4 translocation and Insulin receptor sensitivity
- Irisin induces adipose tissue browning → increased energy expenditure
- IL-15 promotes lipolysis and reduces visceral fat
- Clinical application: Diabetic patients with preserved muscle mass show better glycemic control even at same body weight
Cognitive Function and Mental Health:
- Muscle-derived BDNF and Irisin→BDNF pathway directly support neuroplasticity
- Links physical activity to improved mood, memory, and neuroprotection
- Explains why exercise is as effective as SSRIs for mild-moderate depression
- Selfish Brain context: Myokines help satisfy brain metabolic demands and reduce neuroinflammation, preventing Selfish Brain from triggering appetite/fatigue overrides
Immune Regulation:
- IL-15 enhances NK cell function without promoting autoimmune responses
- IL-6/IL-10 cascade shifts immune system toward regulatory/resolving phenotypes
- Improves immune surveillance against cancer and infections while reducing autoimmune risk
- Selfish Immune System: Myokines help satisfy immune metabolic needs, reducing "inflammatory taxation" on other systems
Wound Healing and Tissue Repair:
- Myokines promote angiogenesis (IL-8), collagen synthesis, and satellite cell activation
- Accelerate recovery from injury and surgery
- Support bone metabolism via osteocalcin cross-talk
Evolutionary Mismatch:
- Modern sedentary environment creates myokine deficiency state
- Hunter-gatherer activity levels (10,000-20,000 steps/day, intermittent high-intensity efforts) maintained constant myokine exposure
- Current populations experience "myokine insufficiency syndrome" contributing to NCDs
Practical Prescription Guidelines:
- Minimum effective dose: 150 minutes/week moderate activity OR 75 minutes/week vigorous activity (WHO guidelines)
- Optimal myokine response: Include 2-3 sessions/week of resistance training or HIIT to recruit type II fibers and maximize IL-6/IL-15/Irisin release
- Clinical monitoring: Track muscle mass (DEXA, BIA), functional capacity (grip strength, sit-to-stand), inflammatory markers (CRP, IL-6), and metabolic markers (HbA1c, Insulin sensitivity)
- Priority populations: Elderly (sarcopenia prevention), chronic inflammatory conditions, metabolic syndrome, depression/anxiety, chronic pain
- Muscle-derived IL-6 can increase 100-fold during exercise (from ~10 pg/mL to >1000 pg/mL) without elevating TNF-α or IL-1β
- Myokine IL-6 is anti-inflammatory; adipose-derived or infection-derived IL-6 is pro-inflammatory—same molecule, opposite effects based on source
- IL-10 release peaks 30-60 minutes AFTER IL-6 elevation, creating a biphasic anti-inflammatory response
- Irisin crosses the blood-brain barrier and induces hippocampal BDNF expression, directly linking muscle contraction to neuroplasticity
- Type II muscle fibers (recruited during high-intensity activity) produce more myokines per contraction than Type I fibers
- Sarcopenia (muscle mass loss) reduces total myokine production capacity by 30-50% in elderly populations
- IL-15 production is proportional to muscle mass—larger muscles provide greater constitutive anti-inflammatory signaling
- A single bout of resistance training elevates myokine levels for 24-72 hours post-exercise (training effect persists beyond exercise window)
- Myokine production declines with age but remains trainable—resistance training in 70-year-olds can restore myokine responses to levels seen in sedentary 30-year-olds
- Chronic sedentary behavior creates a "myokine deficiency state" that contributes to metabolic syndrome, chronic inflammation, and cognitive decline independent of obesity
- IL-6 from muscle stimulates hepatic glucose production acutely but improves Insulin sensitivity chronically—context-dependent dual action
- IL-6 — primary myokine with context-dependent anti-inflammatory effects when muscle-derived; pro-inflammatory when adipose or infection-derived
- IL-10 — anti-inflammatory myokine released 30-60 minutes after IL-6, suppresses TNF-α and IL-1β
- IL-15 — anabolic and lipolytic myokine that enhances NK cell function and muscle protein synthesis
- Irisin — converts white to brown adipose tissue, crosses blood-brain barrier to induce hippocampal BDNF
- BDNF — released directly from muscle and induced in brain via Irisin, promotes neuroplasticity and mood regulation
- physical activity — contraction stimulus for myokine release; intensity and muscle mass recruited determine myokine magnitude
- resistance training — maximally recruits type II fibers and produces highest myokine responses per session
- high-intensity interval training — produces large myokine elevations with shorter time commitment than moderate continuous exercise
- muscle mass — total myokine production capacity scales with muscle quantity; sarcopenia reduces anti-inflammatory signaling
- inflammation — myokines actively resolve chronic inflammation without immune suppression
- chronic inflammation — myokine deficiency from sedentary behavior perpetuates low-grade inflammatory state
- Insulin resistance — myokines (especially IL-6 and Irisin) improve Insulin sensitivity independent of weight loss
- glucose metabolism — IL-6 increases GLUT4 translocation; IL-15 enhances glucose uptake in muscle
- lipolysis — IL-6 activates hormone-sensitive lipase; IL-15 reduces adipose mass
- adipose tissue — myokines reduce adiposity via browning (Irisin), lipolysis (IL-6, IL-15), and metabolic rate increases
- neuroplasticity — BDNF and Irisin from muscle promote synaptic plasticity, neurogenesis, and cognitive function
- depression — myokine-induced BDNF elevation and anti-inflammatory effects mediate exercise's antidepressant properties
- cognitive function — muscle-brain cross-talk via BDNF and Irisin supports memory, learning, and neuroprotection
- Selfish Brain — myokines help meet brain metabolic demands and reduce neuroinflammation, preventing pathological brain resource hoarding
- Selfish Immune System — myokine signaling satisfies immune metabolic needs while maintaining anti-inflammatory phenotype
- wound healing — myokines promote angiogenesis (IL-8), tissue repair, and collagen synthesis
- satellite cells — activated by myokines to support muscle regeneration and hypertrophy
- NK cells — enhanced by IL-15, improving immune surveillance without autoimmune risk
- metabolic flexibility — myokines drive substrate switching and metabolic adaptation to match energy demands
- sedentary behavior — absence of myokine signaling contributes to metabolic dysfunction, inflammation, and cognitive decline
- Module 2 — Immune system and muscle-immune cross-talk
- Module 10 — Muscle as endocrine organ, detailed myokine mechanisms and clinical applications